Vasopressin receptor antagonists in patients with chronic heart failure-Reference-Cited by-同舟云学术

Vasopressin receptor antagonists in patients with chronic heart failure

Published:2016-09-15 Issue:5 Volume:42 Page:492-497
ISSN:0340-9937
Container-title:Herz
language:en
Short-container-title:Herz

Author:

De Vecchis R.,Cantatrione C.,Mazzei D.

Publisher

Springer Science and Business Media LLC

Subject

Cardiology and Cardiovascular Medicine

Link

http://link.springer.com/article/10.1007/s00059-016-4482-9/fulltext.html

Reference35 articles.

1. Zeidel ML (2010) Hyponatremia: mechanisms and newer treatments. Endocr Pract 16:882–887

2. Schrier RW (1990) Body fluid volume regulation in health and disease: a unifying hypothesis. Ann Intern Med 113:155–159

3. Schrier RW (2007) Decreased effective blood volume in edematous disorders: what does this mean? J Am Soc Nephrol 18:2028–2031

4. MacFadyen RJ, Ng Kam Chuen MJ, Davis RC (2010) Loop diuretic therapy in left ventricular systolic dysfunction: Has familiarity bred contempt for a critical but potentially nephrotoxic cardio renal therapy? Eur J Heart Fail 12(7):649–652

5. De Vecchis R, Ciccarelli A, Pucciarelli A (2010) Unloading therapy by intravenous diuretic in chronic heart failure: a double-edged weapon? J Cardiovasc Med (Hagerstown) 11(8):571–574 (Review)

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. RETRACTED: De Vecchis et al. Vasopressin Receptor Antagonists for the Correction of Hyponatremia in Chronic Heart Failure: An Underutilized Therapeutic Option in Current Clinical Practice? J. Clin. Med. 2016, 5, 86;Journal of Clinical Medicine;2024-03-18

2. Vasopressin receptor antagonists: a patent summary (2018-2022);Expert Opinion on Therapeutic Patents;2023-05-04

3. Level of natremia as an index of the condition of the organism of animals under stress;Regulatory Mechanisms in Biosystems;2021-03-12

4. Pharmacotherapy of Chronic Heart Failure;Biomedical and Pharmacology Journal;2018-06-27